GigaGen has been awarded a contract by the Biomedical Advanced Research and Development Authority (BARDA), part of the ...

Singapore’s Agency for Science, Technology and Research (A*STAR) and US biotech incubator Flagship Pioneering have agree to ...

The US Food and Drug Administration (FDA) has removed the partial clinical hold on delpacibart etedesiran (del-desiran/AOC ...

F2G has raised $100 million to advance its lead antifungal drug, olorofim, despite a setback with the FDA requesting further ...

The US FDA has granted Kite’s Yescarta (axicabtagene ciloleucel) a Regenerative Medicine Advanced Therapy (RMAT) designation ...

Japanese biopharma firm PeptiDream says that its wholly-owned PDRadiopharma subsidiary has entered into a strategic ...

Teva Pharmaceutical and mAbxience have signed a second global licensing deal to develop an anti PD-1 oncology biosimilar. The ...

US clinical-stage biotech Arcus Biosciences has entered into a clinical trial collaboration with AstraZeneca on renal cancer ...

Kedrion Biopharma has finalized a long-term agreement with Biotest, now part of Grifols, to commercialize and distribute ...

Ferring Pharmaceuticals has opened a global manufacturing hub in Finland to produce the drug substance for Adstiladrin, its ...

French drug developer Abivax today announced the results of an interim efficacy and safety analysis of an open-label ...

The US Food and Drug Administration (FDA) has determined the shortage of tirzepatide injection, a glucagon-like peptide 1 ...